Salix, Cosmo subsidiary to merge

Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) will merge with an Irish subsidiary of partner Cosmo Pharmaceuticals S.p.A. (SIX:COPN) in a stock deal that will give Cosmo about a 20% stake in

Read the full 296 word article

How to gain access

Continue reading with a
two-week free trial.